Pee test could replace scopes for bladder cancer monitoring
NCT ID NCT05982561
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing BCDx, a urine-based test designed to detect the return of non-muscle invasive bladder cancer (NMIBC) earlier and without a scope. Researchers will enroll 500 people with a history of NMIBC and compare the test's accuracy to standard cystoscopy. If it works, it could offer a simpler, less invasive way to monitor for recurrence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BCDx urine test
What this could lead to
If successful, BCDx could offer a simple, noninvasive urine test to catch bladder cancer recurrence early, reducing the need for frequent cystoscopies.
What could go wrong
This is a diagnostic accuracy study, not a treatment trial. The test may not be sensitive or specific enough to replace standard monitoring, and results may not apply to all bladder cancer patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arkansas Urology Research Center
RECRUITINGLittle Rock, Arkansas, 72211, United States
Contact
Contact
-
Indiana University School of Medicine
RECRUITINGIndianapolis, Indiana, 46202, United States
Contact
-
Washington University
RECRUITINGSt Louis, Missouri, 63130, United States
Contact
Contact